Track topics on Twitter Track topics that are important to you
Allergan PLC acquired public biotech Vitae Pharmaceuticals Inc. (computational drug design), paying $21 per share (a 175% premium) in cash for all Vitae outstanding shares, valuing the transaction at $639mm.
Original Article: Allergan PLC acquires autoimmune-focused Vitae for $639mmNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...